| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.55B | +6.2% |
| Cost of Revenue | $1.60B | +11.0% |
| Gross Profit | $952.7M | -0.8% |
| R&D Expense | $48.8M | -1.8% |
| SG&A Expense | $578.6M | -5.3% |
| Operating Income | $325.3M | +8.5% |
| Pre-tax Income | $272.0M | +8.1% |
| Income Tax | $85.8M | +77.6% |
| Net Income | $188.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $265.6M | -19.5% |
| Accounts Receivable | $455.8M | -7.4% |
| Inventory | $290.7M | +5.9% |
| Current Assets | $1.19B | -2.1% |
| Total Assets | $4.90B | -4.6% |
| Current Liabilities | $344.4M | -17.1% |
| Long-term Debt | $1.91B | -0.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $295.9M | -9.2% |
| Capital Expenditures | $47.8M | +3.2% |
| Investing Cash Flow | -$75.2M | +86.8% |
| Financing Cash Flow | -$275.6M | -195.0% |
| Free Cash Flow | $248.1M | -11.3% |
| -7.7% |
| EPS (Basic) | $0.76 | -7.3% |
| EPS (Diluted) | $0.76 | -7.3% |
| Total Liabilities |
| $2.55B |
| -3.1% |
| Stockholders' Equity | $2.33B | -6.0% |